Breaking News

SCM Pharma Names BD Director

October 17, 2013

Bellamy brings 30 years of experience

Simon Bellamy has been appointed business development director at SCM Pharma. Mr. Bellamy will be responsible for new clinical trials business and small commercial opportunities for the company’s new $10 million facility in Newburn. He has 30 years of experience in the pharmaceutical industry. Most recently he held business development roles at Catalent Pharma Solutions and Piramal Healthcare.
 
Dianne Sharp, managing director at SCM Pharma, said, “Attracting Simon to our business is a major coup given his past experience in the contract manufacturing arena and he will no doubt add a huge amount of value to our exciting growth plans. We now have two of the finest sterile filling facilities in Europe catering for development, clinical trial projects and commercial supply, which gives Simon and his team a compelling service offering to take to the market.”
 
SCM Pharma specializes in the sterile production of products for clinical trials along with the supply of licensed drugs in niche markets. Its new facility completed a successful inspection from the MHRA this past summer.
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.